The Fort Worth Press - Pharma giants to pay $590 mn to US Native Americans over opioids

USD -
AED 3.67302
AFN 70.177799
ALL 94.694858
AMD 399.571201
ANG 1.800481
AOA 912.000034
ARS 1027.729361
AUD 1.603355
AWG 1.8
AZN 1.697676
BAM 1.879673
BBD 2.017107
BDT 119.384911
BGN 1.881012
BHD 0.376934
BIF 2953.447033
BMD 1
BND 1.357194
BOB 6.903412
BRL 6.21685
BSD 0.999039
BTN 85.070401
BWP 13.87506
BYN 3.26939
BYR 19600
BZD 2.010284
CAD 1.43675
CDF 2870.000189
CHF 0.90009
CLF 0.03586
CLP 989.480209
CNY 7.298801
CNH 7.306215
COP 4373.91
CRC 507.256127
CUC 1
CUP 26.5
CVE 106.009258
CZK 24.10875
DJF 177.904853
DKK 7.171097
DOP 60.855358
DZD 135.127343
EGP 50.858598
ERN 15
ETB 127.201346
EUR 0.96095
FJD 2.31865
FKP 0.791982
GBP 0.797448
GEL 2.810197
GGP 0.791982
GHS 14.690824
GIP 0.791982
GMD 71.999964
GNF 8634.310428
GTQ 7.698187
GYD 209.014897
HKD 7.76805
HNL 25.382989
HRK 7.172906
HTG 130.598126
HUF 395.534005
IDR 16213
ILS 3.64741
IMP 0.791982
INR 85.38525
IQD 1308.697741
IRR 42087.498013
ISK 139.549837
JEP 0.791982
JMD 155.655935
JOD 0.709299
JPY 157.086031
KES 129.119811
KGS 86.99942
KHR 4014.412683
KMF 466.124975
KPW 899.999441
KRW 1457.470401
KWD 0.30818
KYD 0.83258
KZT 517.549255
LAK 21848.149928
LBP 89462.854397
LKR 294.435368
LRD 181.893348
LSL 18.576261
LTL 2.95274
LVL 0.604891
LYD 4.904373
MAD 10.074676
MDL 18.432484
MGA 4712.157617
MKD 59.135031
MMK 3247.960992
MNT 3397.99987
MOP 7.992119
MRU 39.880827
MUR 47.070154
MVR 15.402589
MWK 1732.340221
MXN 20.164402
MYR 4.487015
MZN 63.903729
NAD 18.576261
NGN 1541.640096
NIO 36.761173
NOK 11.628915
NPR 136.06247
NZD 1.771166
OMR 0.384748
PAB 0.999039
PEN 3.720135
PGK 4.054781
PHP 58.591972
PKR 278.129073
PLN 4.094575
PYG 7791.44642
QAR 3.634825
RON 4.784295
RSD 112.416046
RUB 99.929361
RWF 1393.656896
SAR 3.75514
SBD 8.383555
SCR 14.26593
SDG 601.501981
SEK 11.078902
SGD 1.3585
SHP 0.791982
SLE 22.8039
SLL 20969.503029
SOS 570.975493
SRD 35.057966
STD 20697.981008
SVC 8.741951
SYP 2512.530243
SZL 18.584334
THB 34.159588
TJS 10.933512
TMT 3.51
TND 3.186697
TOP 2.342101
TRY 35.177625
TTD 6.789044
TWD 32.699497
TZS 2419.99986
UAH 41.889284
UGX 3656.895723
UYU 44.484182
UZS 12897.645363
VES 51.575121
VND 25425
VUV 118.722003
WST 2.762788
XAF 630.424796
XAG 0.033795
XAU 0.000382
XCD 2.70255
XDR 0.765978
XOF 630.424796
XPF 114.617972
YER 250.375036
ZAR 18.612085
ZMK 9001.2026
ZMW 27.648246
ZWL 321.999592
  • RIO

    -0.0300

    59.2

    -0.05%

  • BCC

    0.9500

    123.19

    +0.77%

  • NGG

    -0.1600

    58.86

    -0.27%

  • AZN

    -0.3300

    66.3

    -0.5%

  • GSK

    -0.0300

    34.03

    -0.09%

  • BTI

    0.0400

    36.26

    +0.11%

  • RBGPF

    59.8000

    59.8

    +100%

  • SCS

    0.0800

    11.73

    +0.68%

  • BP

    0.0400

    28.79

    +0.14%

  • CMSD

    0.1000

    23.65

    +0.42%

  • CMSC

    -0.1321

    23.77

    -0.56%

  • BCE

    0.0600

    22.9

    +0.26%

  • RELX

    0.3000

    45.89

    +0.65%

  • RYCEF

    -0.0100

    7.24

    -0.14%

  • VOD

    0.0600

    8.43

    +0.71%

  • JRI

    0.0500

    12.15

    +0.41%

Pharma giants to pay $590 mn to US Native Americans over opioids
Pharma giants to pay $590 mn to US Native Americans over opioids

Pharma giants to pay $590 mn to US Native Americans over opioids

A group of pharmaceutical companies and distributors agreed to pay $590 million to settle lawsuits connected to opioid addiction among Native American tribes, according to a US court filing released Tuesday.

Text size:

The agreement is the latest amid a deluge of litigation spawned by the US opioid crisis, which has claimed more than 500,000 lives over the last 20 years and ensnared some of the largest firms in the world of American medicine.

The companies involved in the latest agreement include Johnson & Johnson and McKesson, according to a filing in an Ohio federal court by a committee of plaintiffs in the case.

Native Americans have "suffered some of the worst consequences of the opioid epidemic of any population in the United States," according to the filing from the Plaintiffs' Tribal Leadership Committee, which cited per-capita death rates compared with other ethnic groups.

"The burden of paying these increased costs has diverted scarce funds from other needs and has imposed severe financial burdens on the tribal plaintiffs."

Johnson & Johnson, McKesson and the other two companies in the accord -- AmerisourceBergen and Cardinal Health -- have previously agreed to a $26 billion global settlement on opioid cases.

J&J said Tuesday the $150 million it agreed to pay in the Native American case has been deducted from what it owes in the global settlement.

"This settlement is not an admission of any liability or wrongdoing and the company will continue to defend against any litigation that the final agreement does not resolve," the company said.

It was unclear if the other companies would take what they owe under the latest agreement from the global settlement.

- 'Measure of justice' -

Robins Kaplan, a law firm negotiating on the behalf of the plaintiffs, said in a statement the agreement must still be approved by the Native American tribes, which are pursuing other claims regarding opioids.

"This initial settlement for tribes in the national opioid litigation is a crucial first step in delivering some measure of justice to the tribes and reservation communities across the United States that have been ground zero for the opioid epidemic," Tara Sutton, an attorney at the firm who negotiated on behalf of the Native Americans.

Douglas Yankton, chairman of the North Dakota-based Spirit Lake Nation, said the money from the settlement would "help fund crucial, on-reservation, culturally appropriate opioid treatment services."

All tribes recognized by the US government, 574 in all, will be able to participate in the agreement, even if they have not filed lawsuits.

The settlement is separate from a prior agreement that resulted in $75 million in payments to the Cherokee Nation from three distribution companies, including McKesson.

Many of the lawsuits regarding the opioid crisis have centered on Purdue Pharma, the manufacturer of OxyContin, a highly addictive prescription painkiller blamed for causing a spike in addiction.

A judge in December overturned the company's bankruptcy plan because it provided some immunity for the owners of the company in exchange for a $4.5 billion payout to victims of the opioid crisis.

The litigation wave has also swamped pharmacies owned by Walmart, Walgreens and CVS, which a jury found in November bear responsibility for the opioid crisis in two counties in Ohio.

C.M.Harper--TFWP